LUV
67
-4
NWL
61
3
VNO
52
-13
ADT
50
2
SE
41
-38
DHR
62
-2
HPE
63
-3
HCA
62
2
VTR
66
-18
D
48
3
PG
50
-21
URBN
59
-11
TSN
46
-16
TSCO
51
-17
WMT
60
-15
BK
66
-2
BRK.B
47
4
EBAY
52
4
GRMN
37
-8
CF
48
6
LUV
67
-4
NWL
61
3
VNO
52
-13
ADT
50
2
SE
41
-38
DHR
62
-2
HPE
63
-3
HCA
62
2
VTR
66
-18
D
48
3
PG
50
-21
URBN
59
-11
TSN
46
-16
TSCO
51
-17
WMT
60
-15
BK
66
-2
BRK.B
47
4
EBAY
52
4
GRMN
37
-8
CF
48
6
Financhill
Back

CrossingBridge Pre-Merger SPAC ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
9

SPC
CrossingBridge Pre-Merger SPAC ETF

Last Price:
$21.45
Seasonality Move:
-1.19%
Sell
29

ZBIO
Zenas BioPharma, Inc.

Last Price:
$34.78
Seasonality Move:
0.59%
Sell
9
CrossingBridge Pre-Merger SPAC ETF (SPC) is a Sell

Is CrossingBridge Pre-Merger SPAC ETF a Buy, Sell or Hold?

  • The current CrossingBridge Pre-Merger SPAC ETF [SPC] share price is $21.55. The Score for SPC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • SPC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
29
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $35.81. The Score for ZBIO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPC Stock Price Chart

What is CrossingBridge Pre-Merger SPAC ETF's stock price today?

  • The CrossingBridge Pre-Merger SPAC ETF share price today is $21.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPC is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $35.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing slight selling pressure.

SPC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.72 Buy
Relative Strength Index (14 RSI): 40.31 Sell
Chaikin Money Flow: 1754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.6 - 21.96) Sell
Bollinger Bands (100): (21.53 - 21.89) Sell

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.86 Buy
Relative Strength Index (14 RSI): 49.55 Sell
Chaikin Money Flow: -89322 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.22 - 39.36) Sell
Bollinger Bands (100): (17.16 - 33.88) Buy

SPC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.57 Sell
20-day SMA: 21.74 Sell
50-day SMA: 21.83 Sell
200-day SMA: 21.41 Buy
8-day EMA: 4.79 Buy
20-day EMA: 2.05 Buy
50-day EMA: 0.85 Buy
200-day EMA: 0.21 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.84 Sell
20-day SMA: 37.69 Sell
50-day SMA: 32.84 Buy
200-day SMA: 17.75 Buy
8-day EMA: 7.96 Buy
20-day EMA: 3.41 Buy
50-day EMA: 1.4 Buy
200-day EMA: 0.36 Buy

CrossingBridge Pre-Merger SPAC ETF Earnings Growth & SPC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

CrossingBridge Pre-Merger SPAC ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):